---
title: "Promazine - Attention Deficit And Disruptive Behavior Disorders"
sidebar: mydoc_sidebar
permalink: db00420-mesh-d019958-1.html
toc: false 
---


Path ID: `DB00420_MESH_D019958_1`
{% include image.html url="images/db00420-mesh-d019958-1.png" file="db00420-mesh-d019958-1.png" alt="db00420-mesh-d019958-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D011395">MESH:D011395 </a> | promazine | Drug |
| <a href="https://identifiers.org/UniProt:P14416">UniProt:P14416 </a> | D(2) dopamine receptor | Protein |
| <a href="https://identifiers.org/GO:0035240">GO:0035240 </a> | dopamine binding | MolecularActivity |
| <a href="https://identifiers.org/MESH:D004298">MESH:D004298 </a> | Dopamine | ChemicalSubstance |
| <a href="https://identifiers.org/HP:0008760">HP:0008760 </a> | Violent behavior | PhenotypicFeature |
| <a href="https://identifiers.org/HP:0000708">HP:0000708 </a> | Behavioral abnormality | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D019958">MESH:D019958 </a> | Attention Deficit and Disruptive Behavior Disorders | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Promazine | DECREASES ACTIVITY OF | D(2) Dopamine Receptor |
| D(2) Dopamine Receptor | POSITIVELY REGULATES | Dopamine Binding |
| Dopamine Binding | POSITIVELY CORRELATED WITH | Dopamine |
| Dopamine | CONTRIBUTES TO | Violent Behavior |
| Dopamine | CONTRIBUTES TO | Behavioral Abnormality |
| Violent Behavior | MANIFESTATION OF | Attention Deficit And Disruptive Behavior Disorders |
| Behavioral Abnormality | MANIFESTATION OF | Attention Deficit And Disruptive Behavior Disorders |
|---------|-----------|---------|

Comment: Promazine is a phenothiazine drug that is uesd in short-term treatment of disturbed behavior and as an antiemetic. Promazine is currently not approved for human use in the United States.

Reference: 
  - [https://go.drugbank.com/drugs/DB00420#mechanism-of-action](https://go.drugbank.com/drugs/DB00420#mechanism-of-action)
  - [https://www.uniprot.org/uniprot/P14416#function](https://www.uniprot.org/uniprot/P14416#function)
  - [https://en.wikipedia.org/wiki/DSM-IV_codes#Attention-deficit_and_disruptive_behavior_disorders](https://en.wikipedia.org/wiki/DSM-IV_codes#Attention-deficit_and_disruptive_behavior_disorders)
